Mithoor Divyashree
Mithoor Divyashree has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Dhanyashree Rai
Department of Environmental Health and Toxicology, Nitte (Deemed to be University), Nitte University Centre for Science Education and Research
3 shared publications- Madhu K. Mani
Nitte University Centre for Science Education and Research (NUCSER), Nitte (Deemed to be University), Paneer Campus, Deralakatte, Mangalore, Karnataka 575018, India
3 shared publications - J. R. Shubha
NITTE Deemed to be University
2 shared publications Neeksha Rao
Department of Environmental Health and Toxicology, Nitte (Deemed to be University), Nitte University Centre for Science Education and Research
2 shared publicationsAndrea Emilia Lobo
Nitte University Center for Science Education and Research (NUCSER), Nitte (Deemed to be University)
1 shared publicationChaithra Raviraj
Nitte (Deemed to be University), Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), Department of Advanced Research Centre
1 shared publication
Latest Publications
- 27 September 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- p. 1-13
Gametophytic responses of Pityrogramma calomelanos to Pb(II) stress: potential application in water pollution assessment
Heavy metals are persistent environmental pollutants that can accumulate in soil and water as a result of anthropogenic activities. Industrial activities, mining, smelting, waste disposal, fossil-f...
- 27 September 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- p. 1-13
Gametophytic responses of Pityrogramma calomelanos to Pb(II) stress: potential application in water pollution assessment
Heavy metals are persistent environmental pollutants that can accumulate in soil and water as a result of anthropogenic activities. Industrial activities, mining, smelting, waste disposal, fossil-f...
- 26 November 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 36 (7) , 1665-1686
Exploration of polyhydroxyalkanoate-producing bacteria in diverse soils with emphasis on bioremediation
Polyhydroxyalkanoates (PHAs) are biodegradable polymers with immense potential as eco-friendly alternatives to conventional plastics. The study aimed to screen for PHA-producing bacteria in different soil samples and evaluating for their hydrocarbon utilization. In the present study, a total of 30 soil samples were collected from different sites, such as petrol bunk, sewage, and garden. Among the total bacterial isolates obtained, 30 showed positive PHA production by preliminary screening Sudan Black B, Nile blue, and Nile red staining techniques. Quantitative estimation of PHA was performed using a shake flask experiment in a minimal medium with an initial pH of 7, 10% (v/v) inoculum, 30°C, 170 rpm at 72 h. The isolate Bacillus subtilis PHAD13 produced the highest PHA 59% extracted by sodium hypochlorite method. Polymers from Bacillus amyloliquefaciens (PHAD7), Bacillus subtilis (PHAD13), Bacillus cereus (NS1), and Klebsiella sp. (NG5) were characterized by FT-IR analysis. GC-MS analysis revealed the presence of PHA copolymer, with tridecanoic acid (C13:0, MCL-PHA), and longer chain monomers (C15:0-C18:1, LCL-PHA); coexistence indicates heterogeneous monomer integration. The bacterial growth on Bushnell-Haas agar supplemented with spent engine oil demonstrated hydrocarbon tolerance indicating its bioremediation potential. The present study demonstrates the dual functional capability of Bacillus subtilis for bioplastic production and hydrocarbon degradation.
- 26 November 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 36 (7) , 1665-1686
Exploration of polyhydroxyalkanoate-producing bacteria in diverse soils with emphasis on bioremediation
Polyhydroxyalkanoates (PHAs) are biodegradable polymers with immense potential as eco-friendly alternatives to conventional plastics. The study aimed to screen for PHA-producing bacteria in different soil samples and evaluating for their hydrocarbon utilization. In the present study, a total of 30 soil samples were collected from different sites, such as petrol bunk, sewage, and garden. Among the total bacterial isolates obtained, 30 showed positive PHA production by preliminary screening Sudan Black B, Nile blue, and Nile red staining techniques. Quantitative estimation of PHA was performed using a shake flask experiment in a minimal medium with an initial pH of 7, 10% (v/v) inoculum, 30°C, 170 rpm at 72 h. The isolate Bacillus subtilis PHAD13 produced the highest PHA 59% extracted by sodium hypochlorite method. Polymers from Bacillus amyloliquefaciens (PHAD7), Bacillus subtilis (PHAD13), Bacillus cereus (NS1), and Klebsiella sp. (NG5) were characterized by FT-IR analysis. GC-MS analysis revealed the presence of PHA copolymer, with tridecanoic acid (C13:0, MCL-PHA), and longer chain monomers (C15:0-C18:1, LCL-PHA); coexistence indicates heterogeneous monomer integration. The bacterial growth on Bushnell-Haas agar supplemented with spent engine oil demonstrated hydrocarbon tolerance indicating its bioremediation potential. The present study demonstrates the dual functional capability of Bacillus subtilis for bioplastic production and hydrocarbon degradation.
- 11 May 2025
- Published by Springer Nature
- p. 163-179
Exploitation of Microbes as a Means for Biofortification of Zinc in Crop Plants
- 11 May 2025
- Published by Springer Nature
- p. 163-179
Exploitation of Microbes as a Means for Biofortification of Zinc in Crop Plants
- 11 May 2025
- Published by Springer Nature
- p. 277-297
Microbes as Tools for the Amelioration of Zinc Phytotoxicity
- 11 May 2025
- Published by Springer Nature
- p. 277-297
Microbes as Tools for the Amelioration of Zinc Phytotoxicity
- 23 April 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 35 (12) , 3735-3751
Bdellovibrio bacteriovorus , a natural microbial predator in the fight against pathogens—one health approach
Multiple drug-resistant bacterial infections have led to an increasing need for an effective disease outbreak response system, such as the One Health platform. While interactions among humans, animals, and ecosystems are crucial and inevitable for survival, the intercommunity transfer of drug resistance genes and the resulting diseases are matters of concern. The concept of bacterial predation and its application in different fields have attracted interest as a natural alternative to traditional antibiotics. Bdellovibrio bacteriovorus, an obligate bacterial predator, preys on a wide range of other bacteria, regardless of their antibiotic resistance status. The present study reviews the potential ability of one of the best studied bacteria among the Bdellovibrio and Like Organisms (BALOs) group B. bacteriovorus, as a One Health solution for pathogen control, delving into its role in interconnected sectors of human, animal, and environmental health, highlighting its prospects as a significant contributor to the One Health approach. Although in vivo animal studies have demonstrated the safety and efficacy of B. bacteriovorus in reducing bacterial burdens in various infection models, clinical trials have not yet been conducted. Understanding the molecular bases of predatory strategies and clinical studies may help in the development of a revolutionary biocontrol agent, such as One Health Solution, for treating infections.
- 23 April 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 35 (12) , 3735-3751
Bdellovibrio bacteriovorus , a natural microbial predator in the fight against pathogens—one health approach
Multiple drug-resistant bacterial infections have led to an increasing need for an effective disease outbreak response system, such as the One Health platform. While interactions among humans, animals, and ecosystems are crucial and inevitable for survival, the intercommunity transfer of drug resistance genes and the resulting diseases are matters of concern. The concept of bacterial predation and its application in different fields have attracted interest as a natural alternative to traditional antibiotics. Bdellovibrio bacteriovorus, an obligate bacterial predator, preys on a wide range of other bacteria, regardless of their antibiotic resistance status. The present study reviews the potential ability of one of the best studied bacteria among the Bdellovibrio and Like Organisms (BALOs) group B. bacteriovorus, as a One Health solution for pathogen control, delving into its role in interconnected sectors of human, animal, and environmental health, highlighting its prospects as a significant contributor to the One Health approach. Although in vivo animal studies have demonstrated the safety and efficacy of B. bacteriovorus in reducing bacterial burdens in various infection models, clinical trials have not yet been conducted. Understanding the molecular bases of predatory strategies and clinical studies may help in the development of a revolutionary biocontrol agent, such as One Health Solution, for treating infections.
- Open Access
- 6 November 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (4) , 2371-2379
Production and Antimicrobial Activities of Pyocyanin Extracts from Pseudomonas aeruginosa
Pyocyanin is a blue-green phenazine pigment synthesized by Pseudomonas aeruginosa that has significant biotechnological applications. The present study aims to investigate pyocyanin extracts of multi-drug resistant P. aeruginosa isolates sourced from hospital wastewater and evaluate their antimicrobial activity against a panel of clinically relevant pathogens such as Staphylococcus aureus, Salmonella typhi, Achromobacter xylosoxidans and Candida albicans. Nutrient broth and King’s A broth supplemented with 1% nutrient supplements such as rice water and groundnut cake powder were used as a production medium. Extracted pyocyanin was confirmed by FTIR analysis. The isolates P8 and P9 demonstrated of varying concentrations of pyocyanin in different media. Isolate P8 showed maximum pyocyanin production in King’s A broth compared to nutrient broth with pyocyanin yields 14.34 (µg/mL) and 5.63 (µg/mL), respectively, without the nutrient supplements. Preliminary antimicrobial activity of the pyocyanin extracts exhibited substantial inhibition of tested bacterial culture at a concentration of 25 mg/µl; however, did not show any antifungal activity against tested fungi.
- 6 November 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (4) , 2371-2379
Open AccessProduction and Antimicrobial Activities of Pyocyanin Extracts from Pseudomonas aeruginosa
Pyocyanin is a blue-green phenazine pigment synthesized by Pseudomonas aeruginosa that has significant biotechnological applications. The present study aims to investigate pyocyanin extracts of multi-drug resistant P. aeruginosa isolates sourced from hospital wastewater and evaluate their antimicrobial activity against a panel of clinically relevant pathogens such as Staphylococcus aureus, Salmonella typhi, Achromobacter xylosoxidans and Candida albicans. Nutrient broth and King’s A broth supplemented with 1% nutrient supplements such as rice water and groundnut cake powder were used as a production medium. Extracted pyocyanin was confirmed by FTIR analysis. The isolates P8 and P9 demonstrated of varying concentrations of pyocyanin in different media. Isolate P8 showed maximum pyocyanin production in King’s A broth compared to nutrient broth with pyocyanin yields 14.34 (µg/mL) and 5.63 (µg/mL), respectively, without the nutrient supplements. Preliminary antimicrobial activity of the pyocyanin extracts exhibited substantial inhibition of tested bacterial culture at a concentration of 25 mg/µl; however, did not show any antifungal activity against tested fungi.
- Open Access
- 23 January 2023
- Published by IWA Publishing in Journal of Water and Health
- Vol. 21 (2) , 147-159
Predatory efficacy of Bdellovibrio stolpii isolated from the wastewater sources against the multidrug-resistant clinical isolates
The present study investigated the predatory efficacy of Bdellovibrio isolated from untreated hospital wastewater sources against human pathogens. Bdellovibrio is a Gram-negative, motile, uniflagellate predatory bacteria present in the environment, which directly predates on other bacteria, including human pathogens. In the present study, 30 hospital effluent samples were collected and screened for Bdellovibrio. A total of 11 Bdellovibrio isolates were obtained by the double-layer agar technique. All the isolates were identified by amplification of the 16S rDNA coding region using polymerase chain reaction (PCR) and confirmed as Bdellovibrio stolpii. The lytic activity of confirmed isolates was investigated against four Gram-negative bacteria Pseudomonas aeruginosa ADW44, Pseudomonas aeruginosa 27853(ATCC Strain), V. cholerae and Salmonella typhimurium of clinical origin obtained from the institutional repository. Among the 11 isolates, three Bdellovibrio isolates NBd1, YBd1 and RBd1 demonstrated the ability to prey upon the tested clinical isolates. To the best of our knowledge, this is the first report on the isolation of B. stolpii from hospital wastewater settings in India with broad and high bacteriolytic activity.
- 23 January 2023
- Published by IWA Publishing in Journal of Water and Health
- Vol. 21 (2) , 147-159
Open AccessPredatory efficacy of Bdellovibrio stolpii isolated from the wastewater sources against the multidrug-resistant clinical isolates
The present study investigated the predatory efficacy of Bdellovibrio isolated from untreated hospital wastewater sources against human pathogens. Bdellovibrio is a Gram-negative, motile, uniflagellate predatory bacteria present in the environment, which directly predates on other bacteria, including human pathogens. In the present study, 30 hospital effluent samples were collected and screened for Bdellovibrio. A total of 11 Bdellovibrio isolates were obtained by the double-layer agar technique. All the isolates were identified by amplification of the 16S rDNA coding region using polymerase chain reaction (PCR) and confirmed as Bdellovibrio stolpii. The lytic activity of confirmed isolates was investigated against four Gram-negative bacteria Pseudomonas aeruginosa ADW44, Pseudomonas aeruginosa 27853(ATCC Strain), V. cholerae and Salmonella typhimurium of clinical origin obtained from the institutional repository. Among the 11 isolates, three Bdellovibrio isolates NBd1, YBd1 and RBd1 demonstrated the ability to prey upon the tested clinical isolates. To the best of our knowledge, this is the first report on the isolation of B. stolpii from hospital wastewater settings in India with broad and high bacteriolytic activity.
- Open Access
- 7 December 2021
- Published by IWA Publishing in Journal of Water and Health
- Vol. 20 (1) , 176-184
Association of exopolysaccharide genes in biofilm developing antibiotic-resistant Pseudomonas aeruginosa from hospital wastewater
The study aimed to examine the relationship between antibiotic resistance, biofilm formation and genes responsible for biofilm formation. Sixty-six Pseudomonas aeruginosa isolates were obtained from hospital wastewater and analyzed for their antibiotic resistance. Biofilm production among the isolates was tested by indirect quantification method crystal violet assay. Biofilm-associated genes among these isolates psl, alg, and pel were also checked. The maximum resistance was observed for ampicillins (88.24%) followed by nalidixic (83.82%), and nitrofurantoin (64.71%), respectively. Biofilm phenotypes are distributed in the following categories: high 39.39% (n = 26); moderate 57.57% (n = 38), and weak 3.0% (n = 2). Among the total isolates, biofilm-associated genes were detected in 84.84% (n = 56) of isolates and the remaining isolates 15.15% (n = 10) did not harbor any genes. In this study, pslB was the most predominant gene observed (71.21%, n = 47) followed by pslA (57.57%, n = 38), pelA (45.45%, n = 30), algD (43.93%, n = 29), and pelD (27.27%, n = 18), respectively. The present study reveals that the majority of the isolates are multidrug resistant being moderate and high biofilm formers. The study implies that biofilm acts as a machinery for bacteria to survive in the hospital effluent which is an antibiotic stress environment.
- 7 December 2021
- Published by IWA Publishing in Journal of Water and Health
- Vol. 20 (1) , 176-184
Open AccessAssociation of exopolysaccharide genes in biofilm developing antibiotic-resistant Pseudomonas aeruginosa from hospital wastewater
The study aimed to examine the relationship between antibiotic resistance, biofilm formation and genes responsible for biofilm formation. Sixty-six Pseudomonas aeruginosa isolates were obtained from hospital wastewater and analyzed for their antibiotic resistance. Biofilm production among the isolates was tested by indirect quantification method crystal violet assay. Biofilm-associated genes among these isolates psl, alg, and pel were also checked. The maximum resistance was observed for ampicillins (88.24%) followed by nalidixic (83.82%), and nitrofurantoin (64.71%), respectively. Biofilm phenotypes are distributed in the following categories: high 39.39% (n = 26); moderate 57.57% (n = 38), and weak 3.0% (n = 2). Among the total isolates, biofilm-associated genes were detected in 84.84% (n = 56) of isolates and the remaining isolates 15.15% (n = 10) did not harbor any genes. In this study, pslB was the most predominant gene observed (71.21%, n = 47) followed by pslA (57.57%, n = 38), pelA (45.45%, n = 30), algD (43.93%, n = 29), and pelD (27.27%, n = 18), respectively. The present study reveals that the majority of the isolates are multidrug resistant being moderate and high biofilm formers. The study implies that biofilm acts as a machinery for bacteria to survive in the hospital effluent which is an antibiotic stress environment.
- Open Access
- 23 November 2021
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 15 (4) , 2403-2408
Detection and Real-time PCR Assay for the Quantification of Carbapenemase Gene blablaNDM-1 in Hospital Effluent
This study aims to isolate gram-negative bacteria (GNB) harboring the gene NDM-1 from the tertiary care hospital effluents. Also, aims to evaluate the relative copy number of blaNDM-1 carried by the positive isolates. The study isolated 215 GNB from 40 effluent samples. The antibiotic susceptibility tests for carbapenems were performed using disc diffusion assay. The isolates resistant to either meropenem or imipenem were checked for the existence of MBL by phenotypic methods. The isolates carrying NDM-1 gene were genotypically confirmed by Polymerase chain reaction (PCR). The gene copy number of blaNDM- were determined by quantative real-time PCR. A total of 22 isolates showed phenotypic resistance to carbapenems and were characterized by biochemical methods. Among them, 12 harbored NDM-1 gene by PCR; these bacteria were subjected to qPCR for determining the absolute copy numbers of the NDM-1 gene on it. The gene abundance in the strains was in the range of 3.28× 105 to 6.05× 106 copies/ ng of DNA. Hospital effluents are important pool of antibiotic-resistant bacteria harboring the blaNDM-1 and infections caused by these bacteria are difficult to treat. Hence, the present study stresses the need for stringent antibiotic use and efficient wastewater treatment policies in these hospital settings, which is paramount in achieving sustainable health.
- 23 November 2021
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 15 (4) , 2403-2408
Open AccessDetection and Real-time PCR Assay for the Quantification of Carbapenemase Gene blablaNDM-1 in Hospital Effluent
This study aims to isolate gram-negative bacteria (GNB) harboring the gene NDM-1 from the tertiary care hospital effluents. Also, aims to evaluate the relative copy number of blaNDM-1 carried by the positive isolates. The study isolated 215 GNB from 40 effluent samples. The antibiotic susceptibility tests for carbapenems were performed using disc diffusion assay. The isolates resistant to either meropenem or imipenem were checked for the existence of MBL by phenotypic methods. The isolates carrying NDM-1 gene were genotypically confirmed by Polymerase chain reaction (PCR). The gene copy number of blaNDM- were determined by quantative real-time PCR. A total of 22 isolates showed phenotypic resistance to carbapenems and were characterized by biochemical methods. Among them, 12 harbored NDM-1 gene by PCR; these bacteria were subjected to qPCR for determining the absolute copy numbers of the NDM-1 gene on it. The gene abundance in the strains was in the range of 3.28× 105 to 6.05× 106 copies/ ng of DNA. Hospital effluents are important pool of antibiotic-resistant bacteria harboring the blaNDM-1 and infections caused by these bacteria are difficult to treat. Hence, the present study stresses the need for stringent antibiotic use and efficient wastewater treatment policies in these hospital settings, which is paramount in achieving sustainable health.
- 6 January 2020
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 27 (2) , 120-134
Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?
: In this era of multi-drug resistance (MDR), antimicrobial peptides (AMPs) are one of the most promising classes of potential drug candidates to combat communicable as well as noncommunicable diseases such as cancers and diabetes. AMPs show a wide spectrum of biological activities which include antiviral, antifungal, anti-mitogenic, anticancer, and anti-inflammatory properties. Apart from these prospective therapeutic potentials, the AMPs can act as food preservatives and immune modulators. Therefore, AMPs have the potential to replace conventional drugs and may gain a significant global drug market share. Although several AMPs have shown therapeutic potential in vitro or in vivo, in most cases they have failed the clinical trial owing to various issues. In this review, we discuss in brief (i) molecular mechanisms of AMPs in various diseases, (ii) importance of AMPs in pharmaceutical industries, (iii) the challenges in using AMPs as therapeutics and how to overcome, (iv) available AMP therapeutics in market, and (v) AMPs under clinical trials. Here, we specifically focus on the therapeutic AMPs in the areas of dermatology, surgery, oncology and metabolic diseases.
- 6 January 2020
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 27 (2) , 120-134
Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?
: In this era of multi-drug resistance (MDR), antimicrobial peptides (AMPs) are one of the most promising classes of potential drug candidates to combat communicable as well as noncommunicable diseases such as cancers and diabetes. AMPs show a wide spectrum of biological activities which include antiviral, antifungal, anti-mitogenic, anticancer, and anti-inflammatory properties. Apart from these prospective therapeutic potentials, the AMPs can act as food preservatives and immune modulators. Therefore, AMPs have the potential to replace conventional drugs and may gain a significant global drug market share. Although several AMPs have shown therapeutic potential in vitro or in vivo, in most cases they have failed the clinical trial owing to various issues. In this review, we discuss in brief (i) molecular mechanisms of AMPs in various diseases, (ii) importance of AMPs in pharmaceutical industries, (iii) the challenges in using AMPs as therapeutics and how to overcome, (iv) available AMP therapeutics in market, and (v) AMPs under clinical trials. Here, we specifically focus on the therapeutic AMPs in the areas of dermatology, surgery, oncology and metabolic diseases.